Organisation:
NICE
Consultation:
Atypical haemolytic uraemic syndrome ‐ ravulizumab ID1530
Status:
Submitted
NICE accredited clinical practice guidelines
Analyses about the care provided to patients at UK renal centres.
A report on the nationwide collection of AKI warning test scores.